Evaluation of patients with suspected laryngopharyngeal reflux: A practical approach

Current Gastroenterology Reports

Volumn 13, Issue 3, 2011, Pages 213-218

  Abou Ismail, Anas ^a   Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic laryngitis; Cough; Dysphonia; Extraesophageal reflux; Globus; Laryngoscopy; pH monitoring; Proton pump inhibitors; Reflux

Indexed keywords

ESOMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; LIFESTYLE MODIFICATION; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH FUNDOPLICATION; SYMPTOM;

ESOPHAGEAL PH MONITORING; FUNDOPLICATION; HUMANS; LARYNGOSCOPY; LARYNX; PROTON PUMP INHIBITORS; REGURGITATION, GASTRIC;

EID: 79955899406     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-011-0184-x     Document Type: Article

References (46)

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101 (8):1900-20. quiz 43.
2. Moore JM, Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease: real or imagined? Curr Opin Gastroenterol. 2010;26(4):389-94.
3. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1(5):333-44. (Pubitemid 37248052)
4. Vaezi MF. Laryngitis: from the gastroenterologist's point of view. In: Vaezi MF, editor. Extraesophageal reflux. San Diego: Plural; 2009. p. 37-47.
5. Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg. 2000;123(4):385-8.
6. Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med. 2000;108(Suppl 4a):112S-9S.
7. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101(4 Pt 2 Suppl 53):1-78.
8. Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol. 2004;99(11):2098-106. (Pubitemid 39524697)
9. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16(2):274-7. (Pubitemid 36626833)
10. Ahmed TF, Khandwala F, Abelson TI, et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol. 2006;101(3):470-8. (Pubitemid 43340921)
11. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice. 2002;16(4):564-79. (Pubitemid 36626819)
12. Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope. 2005;115(12):2256-61. (Pubitemid 44391645)
13. Vavricka SR, Storck CA, Wildi SM, et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol. 2007;102(4):716-22. (Pubitemid 46496637)
14. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001;111(8):1313-7. (Pubitemid 32730172)
15. Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope. 2002;112(6):1019-24. (Pubitemid 34615059)
16. Kelchner LN, Horne J, Lee L, et al. Reliability of speech-language pathologist and otolaryngologist ratings of laryngeal signs of reflux in an asymptomatic population using the reflux finding score. J Voice. 2007;21(1):92-100. (Pubitemid 46039795)
17. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope. 2005;115(7):1230-8. (Pubitemid 40962361)
18. Noordzij JP, Khidr A, Desper E, et al. Correlation of pH probemeasured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope. 2002;112(12):2192-5. (Pubitemid 35417042)
19. Merati AL, Lim HJ, Ulualp SO, Toohill RJ. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2005;114(3):177-82. (Pubitemid 40381531)
20. Oelschlager BK, Eubanks TR, Maronian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageal-laryngeal reflux. J Gastrointest Surg. 2002;6 (2):189-94. (Pubitemid 40433571)
21. Joniau S, Bradshaw A, Esterman A, Carney AS. Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg. 2007;136(5):686-92. (Pubitemid 46660238)
22. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with 'reflux laryngitis'. Gastroenterology. 1991;100(2):305-10.
23. Ahmed T, Vaezi MF. The role of pH monitoring in extraesophageal gastroesophageal reflux disease. Gastrointest Endosc Clin N Am. 2005;15(2):319-31. (Pubitemid 40269261)
24. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92(5):825-9. (Pubitemid 27200799)
25. Kawamura O, Aslam M, Rittmann T, et al. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol. 2004;99(6):1000-10. (Pubitemid 38917800)
26. Eubanks TR, Omelanczuk P, Hillel A, et al. Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy. Am J Surg. 2001;181 (5):466-70. (Pubitemid 32614119)
27. Ulualp SO, Toohill RJ, Shaker R. Outcomes of acid suppressive therapy in patients with posterior laryngitis. Otolaryngol Head Neck Surg. 2001;124(1):16-22. (Pubitemid 32096773)
28. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55(10):1398-402. (Pubitemid 44476780)
29. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006;93(12):1483-7. (Pubitemid 44893649)
30. Vaezi MF. "Refractory GERD": acid, nonacid, or not GERD? Am J Gastroenterol. 2004;99(6):989-90.
31. Vaezi MF. Role of impedance/pH monitoring in refractory GERD: let's be careful out there! Gastroenterology. 2007;132(4):1621-2. discussion 2.
32. Kahrilas PJ, Sifrim D: High-resolution manometry and impedance-pH/ manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008;135(3):756-69. This article provides an excellent review for better understanding of the role of impedance monitoring in GERD.
33. Pritchett JM, Aslam M, Slaughter JC, et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7(7):743-8.
34. Smith JA, Decalmer S, Kelsall A, et al.: Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology. 2010;139(3):754-62. The authors report a novel technique in detecting cough and associating events with reflux measures.
35. Vaezi MF, Slaughter JC, Smith BS, et al.: Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy. Aliment Pharmacol Ther. 2010;32(7):916-24. This article describes a recent study suggesting the poor sensitivity of dilated intercelluar space in GERD and LPR.
36. Park S, Chun HJ, Keum B, et al. An electron microscopic study - correlation of gastroesophageal reflux disease and laryngopharyngeal reflux. Laryngoscope. 2010;120(7):1303-8.
37. Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebocontrol trial. Otolaryngol Head Neck Surg. 2004;131(4):342-50. (Pubitemid 39298192)
38. Kahrilas PJ, Shaheen NJ, Vaezi MF: American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135 (4):1392-413, 413 e1-5. This article provides the most recent American Gastroenterological Association guidelines for GERD.
39. Qadeer MA, Phillips CO, Lopez AR, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a metaanalysis of randomized controlled trials. Am J Gastroenterol. 2006;101(11):2646-54. (Pubitemid 44665265)
40. Fass R, Noelck N, Willis MR, et al. The effect of esomeprazole 20 mg twice daily on acoustic and perception parameters of the voice in laryngopharyngeal reflux. Neurogastroenterol Motil. 2010;22(2):134-41-e44-5.
41. Shaheen NJ, Crockett SD, Bright SD, et al.: Randomised clinical trial: high-dose acid suppression for chronic cough - a doubleblind, placebo-controlled study. Aliment Pharmacol Ther. 2010.
42. Lam PK, Ng ML, Cheung TK, et al. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebocontrolled trial. Clin Gastroenterol Hepatol. 2010;8(9):770-6.
43. Vaezi MF, Hagaman DD, Slaughter JC, et al.: Proton pump inhibitor therapy improves symptoms in postnasal drainage. Gastroenterology. 2010;139(6):1887-93 e1; quiz e11.
44. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005;17(3):332-40. (Pubitemid 40768905)
45. Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100(2):283-9. (Pubitemid 40314510)
46. Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol. 2006;4(4):433-41.